André Lemay

article 2009

Behandlung mit einem intranasalen oder subkutan verabreichten LH-RH-Agonisten zur Unterdrückung der Ovarialfunktion bei der Behandlung der Endometriose

·doi:10.1159/000270926

other 2008

Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain

Fertility and sterility ·doi:10.1016/j.fertnstert.2007.06.019

OBJECTIVE: To evaluate the levels of interleukin-1beta (IL1beta) and its inhibitory soluble interleukin-1 receptor type II (IL1R2) in the peritoneal fluid (PF) of normal women and patients with endometriosis suffering from pelvic pain and i…

article 2002

Estradiol and Interleukin-1β Exert a Synergistic Stimulatory Effect on the Expression of the Chemokine Regulated upon Activation, Normal T Cell Expressed, and Secreted in Endometriotic Cells

The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2002-020106

Endometriosis, commonly associated with intraperitoneal inflammation, is estrogen dependent. Possible links between the immunoinflammatory and endocrine changes observed in endometriotic women have been poorly understood. In this study, we …

article 2001

Comparative Effect of Danazol and a GnRH Agonist on Monocyte Chemotactic Protein‐1 Expression by Endometriotic Cells

American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/j.8755-8920.2001.450204.x

PROBLEM: Endometriosis is associated with a chronic inflammatory process, and the increased number of activated peritoneal macrophages is one of the major hallmarks of this process. The medical treatment of the disease, which is based on th…

article 2000

Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis

Fertility and Sterility ·doi:10.1016/s0015-0282(00)01540-5

article 2000

Medroxyprogesterone improved symptoms of endometriosis in infertile women

·doi:10.1054/ebog.2000.0194

article 1999

Hormone replacement added to goserelin therapy for endometriosis reduced bone loss and hot flushes and Leuprolide acetate depot, with progestin±estrogen, relieved endometriosis pain and reduced bone loss

·doi:10.1054/ebog.1999.0039

article 1999

Immunohistochemical localization of insulin-like growth factor–binding protein-3 in eutopic and ectopic endometrial tissues

Fertility and Sterility ·doi:10.1016/s0015-0282(99)00443-4

article 1999

Physiological and Cytogenetic Characterization of Immortalized Human Endometriotic Cells Containing Episomal Simian Virus 40 DNA

The American journal of pathology ·doi:10.1016/s0002-9440(10)65376-x

article 1997

Immunoblot Detection of Decreased Antibodies to Haptoglobin-Like Protein in the Serum of Infertile Women with or without Endometriosis1

Biology of reproduction ·doi:10.1095/biolreprod57.1.178

The purpose of this study was to find out differences in the levels of antibodies to distinct antigens in the serum of fertile versus infertile patients with and without endometriosis and to identify these antigens. Blood was collected from…

article 1996

Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosis

American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(96)70115-1

article 1995

Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture

American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(95)90578-2

article 1995

N-terminal truncated forms of insulin-like growth factor binding protein-3 in the peritoneal fluid of women without laparoscopic evidence of endometriosis

Fertility and Sterility ·doi:10.1016/s0015-0282(16)57362-2

article 1993

Heparin-sepharose binding growth factors in peritoneal fluid of women with endometriosis

·doi:10.1016/s0015-0282(16)55621-0

article 1991

Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol

Clinical endocrinology ·doi:10.1111/j.1365-2265.1991.tb03541.x

OBJECTIVE: The evaluation of cholesterol fractions and apoproteins during ovarian suppression by a GnRH agonist implant vs danazol in the treatment of endometriosis. DESIGN: A randomized study in 33 patients comparing goserelin (3.6 mg/4 we…

article 1991

Gonadotrophin releasing hormone agonist suppressive treatment of ovarian function decreases serum LH‐β and bloactive LH but maintains elevated levels of LH‐α

Clinical endocrinology ·doi:10.1111/j.1365-2265.1991.tb00293.x

Ten patients with endometriosis were treated by a continuous subcutaneous infusion of the GnRH agonist buserelin for 6 months. Although serum oestradiol decreased into the menopausal range within 2 weeks after starting treatment, serum LH l…

article 1988

Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis

American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(88)90128-7

article 1988

Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist

Fertility and Sterility ·doi:10.1016/s0015-0282(16)59887-2

article 1988

Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase

Fertility and Sterility ·doi:10.1016/s0015-0282(16)59764-7

article 1987

LH-RH agonist treatment of endometriosis.

Contributions to gynecology and obstetrics